Physician profile
Silke N Hunter
NPI 1275854028
$2,987.44
in general payments reported to CMS, 2019-2025
18 companies · $1,931 in 2025
The $1,931 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.79 · 2020: $138 · 2022: $29.60 · 2023: $277 · 2024: $581 · 2025: $1,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Travel and Lodging: $546 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.12 |
| Travel and Lodging | $545.63 |
| Education | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,024.01 | 2024-2025 | 3m Cavilon, Activ.A.C., Kerramax Care |
| Kerecis Limited | $689.46 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $377.38 | 2020-2025 | Oasis, Stravix, Grafix |
| Integra Lifesciences Corporation | $213.69 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $197.36 | 2024-2025 | Affinity |
| Progenacare Global, LLC | $158.90 | 2023-2024 | |
| Reprise Biomedical, INC. | $50.38 | 2020-2025 | Miro3d |
| Paratek Pharmaceuticals, INC. | $41.65 | 2025 | Nuzyra |
| Allergan, INC. | $37.29 | 2020 | |
| Abbvie INC. | $35.96 | 2025 | |
| Reddress USA, INC. | $34.93 | 2023 | |
| Urgo Medical North America, LLC | $25.30 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Team 1, LLC | $24.48 | 2024 | |
| Convatec INC. | $16.82 | 2024 | |
| Kci USA, INC. | $15.86 | 2023 | Activ.A.C., Promogran Prisma |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $15.45 | 2019 | |
| Pfizer INC. | $14.34 | 2019 | |
| Medtronic, INC. | $14.18 | 2023 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silke Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.